BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 29291440)

  • 1. Nitrogen-containing ecdysteroid derivatives vs. multi-drug resistance in cancer: Preparation and antitumor activity of oximes, oxime ethers and a lactam.
    Vágvölgyi M; Martins A; Kulmány Á; Zupkó I; Gáti T; Simon A; Tóth G; Hunyadi A
    Eur J Med Chem; 2018 Jan; 144():730-739. PubMed ID: 29291440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Backstabbing P-gp: Side-Chain Cleaved Ecdysteroid 2,3-Dioxolanes Hyper-Sensitize MDR Cancer Cells to Doxorubicin without Efflux Inhibition.
    Hunyadi A; Csábi J; Martins A; Molnár J; Balázs A; Tóth G
    Molecules; 2017 Jan; 22(2):. PubMed ID: 28125071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of α,β-Unsaturated Carbonyl-Based Compounds, Oxime and Oxime Ether Analogs as Potential Anticancer Agents for Overcoming Cancer Multidrug Resistance by Modulation of Efflux Pumps in Tumor Cells.
    Qin HL; Leng J; Zhang CP; Jantan I; Amjad MW; Sher M; Naeem-Ul-Hassan M; Hussain MA; Bukhari SN
    J Med Chem; 2016 Apr; 59(7):3549-61. PubMed ID: 27010345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of potential anticancer multi-targeted ligustrazine based cyclohexanone and oxime analogs overcoming the cancer multidrug resistance.
    Zha GF; Qin HL; Youssif BGM; Amjad MW; Raja MAG; Abdelazeem AH; Bukhari SNA
    Eur J Med Chem; 2017 Jul; 135():34-48. PubMed ID: 28431353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significant activity of ecdysteroids on the resistance to doxorubicin in mammalian cancer cells expressing the human ABCB1 transporter.
    Martins A; Tóth N; Ványolós A; Béni Z; Zupkó I; Molnár J; Báthori M; Hunyadi A
    J Med Chem; 2012 Jun; 55(11):5034-43. PubMed ID: 22578055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and In Vitro Antitumor Activity of Naringenin Oxime and Oxime Ether Derivatives.
    Latif AD; Gonda T; Vágvölgyi M; Kúsz N; Kulmány Á; Ocsovszki I; Zomborszki ZP; Zupkó I; Hunyadi A
    Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31052551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of phenylselenoether-hydantoin hybrids as ABCB1 efflux pump modulating agents with cytotoxic and antiproliferative actions in resistant T-lymphoma.
    Ali W; Spengler G; Kincses A; Nové M; Battistelli C; Latacz G; Starek M; Dąbrowska M; Honkisz-Orzechowska E; Romanelli A; Rasile MM; Szymańska E; Jacob C; Zwergel C; Handzlik J
    Eur J Med Chem; 2020 Aug; 200():112435. PubMed ID: 32505850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and evaluation of novel alkannin and shikonin oxime derivatives as potent antitumor agents.
    Wang R; Zhang X; Song H; Zhou S; Li S
    Bioorg Med Chem Lett; 2014 Sep; 24(17):4304-7. PubMed ID: 25127868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, Synthesis, and Biological Evaluation of Novel Thiazolyl Substituted Bis-pyrazole Oxime Derivatives with Potent Antitumor Activities by Selectively Inducing Apoptosis and ROS in Cancer Cells.
    Xiong B; Chen S; Zhu P; Huang M; Gao W; Zhu R; Qian J; Peng Y; Zhang Y; Dai H; Ling Y
    Med Chem; 2019; 15(7):743-754. PubMed ID: 30147012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of some steroidal oximes, lactams, thiolactams and their antitumor activities.
    Krstić NM; Bjelaković MS; Zizak Z; Pavlović MD; Juranić ZD; Pavlović VD
    Steroids; 2007 May; 72(5):406-14. PubMed ID: 17433824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery and synthesis of sulfur-containing 6-substituted 5,8-dimethoxy-1,4-naphthoquinone oxime derivatives as new and potential anti-MDR cancer agents.
    Huang G; Dong JY; Zhang QJ; Meng QQ; Zhao HR; Zhu BQ; Li SS
    Eur J Med Chem; 2019 Mar; 165():160-171. PubMed ID: 30677614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and antiproliferative activity of some androstene oximes and their O-alkylated derivatives.
    Acharya PC; Bansal R
    Arch Pharm (Weinheim); 2014 Mar; 347(3):193-9. PubMed ID: 24343881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and synthesis of new potent N,N-bis(arylalkyl)piperazine derivatives as multidrug resistance (MDR) reversing agents.
    Dei S; Coronnello M; Bartolucci G; Manetti D; Romanelli MN; Udomtanakunchai C; Salerno M; Teodori E
    Eur J Med Chem; 2018 Mar; 147():7-20. PubMed ID: 29421572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ecdysteroids sensitize MDR and non-MDR cancer cell lines to doxorubicin, paclitaxel, and vincristine but tend to protect them from cisplatin.
    Martins A; Sipos P; Dér K; Csábi J; Miklos W; Berger W; Zalatnai A; Amaral L; Molnár J; Szabó-Révész P; Hunyadi A
    Biomed Res Int; 2015; 2015():895360. PubMed ID: 26075272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxicity of Synthesized 1,4-Naphthoquinone Oxime Derivatives on Selected Human Cancer Cell Lines.
    Zhang Q; Dong J; Cui J; Huang G; Meng Q; Li S
    Chem Pharm Bull (Tokyo); 2018; 66(6):612-619. PubMed ID: 29863062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and structure-activity relationships of novel ecdysteroid dioxolanes as MDR modulators in cancer.
    Martins A; Csábi J; Balázs A; Kitka D; Amaral L; Molnár J; Simon A; Tóth G; Hunyadi A
    Molecules; 2013 Dec; 18(12):15255-75. PubMed ID: 24335576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel curcumin derivative which inhibits P-glycoprotein, arrests cell cycle and induces apoptosis in multidrug resistance cells.
    Lopes-Rodrigues V; Oliveira A; Correia-da-Silva M; Pinto M; Lima RT; Sousa E; Vasconcelos MH
    Bioorg Med Chem; 2017 Jan; 25(2):581-596. PubMed ID: 27908756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of selenocompounds with promising properties to reverse cancer multidrug resistance.
    Domínguez-Álvarez E; Gajdács M; Spengler G; Palop JA; Marć MA; Kieć-Kononowicz K; Amaral L; Molnár J; Jacob C; Handzlik J; Sanmartín C
    Bioorg Med Chem Lett; 2016 Jun; 26(12):2821-2824. PubMed ID: 27156771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro adjuvant antitumor activity of various classes of semi-synthetic poststerone derivatives.
    Savchenko RG; Nové M; Spengler G; Hunyadi A; Parfenova LV
    Bioorg Chem; 2021 Jan; 106():104485. PubMed ID: 33261846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological evaluation of sulfur-containing shikonin oxime derivatives as potential antineoplastic agents.
    Huang G; Zhao HR; Meng QQ; Zhang QJ; Dong JY; Zhu BQ; Li SS
    Eur J Med Chem; 2018 Jan; 143():166-181. PubMed ID: 29174813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.